News on this topic
0
0
Similar to This
Previous
4
3
5
5
0
0 7
4
1 3
Profile picture of The Financial Express
The Financial Express
C−
 Oct 02 25
Roche commits $1.9 bn investment in India over next 5 yrs: Swiss healthcare giant Roche Pharma announced a major expansion, committing 1.5 billion Swiss francs ...
financialexpress.com/business/industry/roche-commits-1-9-bn-investment-in-india-over-next-5-yrs/3996063/
Roche commits $1.9 bn investment in India over next 5 yrs
0 similar articles
0
1
18
0 11
Profile picture of handelszeitung.ch
handelszeitung.ch
C−
 Jan 30 25
Pharmaceuticals: Roche to grow in 2024 and generate 60.5 billion Swiss francs in sales
handelszeitung.ch/unternehmen/roche-ceo-schinecker-verdiente-100-millionen-franken-790505
Pharmaceuticals: Roche to grow in 2024 and generate 60.5 billion Swiss ...
0 similar articles
0
0
Profile picture of Reuters
Reuters
A
 Oct 09 24
Roche CEO: breast cancer pill could enter $12 bln market if trials succeed: Roche's experimental oral drug for breast cancer giredestrant could enter a market ...
reuters.com/business/healthcare-pharmaceuticals/roche-ceo-breast-cancer-pill-could-be-10-bln-chf-market-if-trials-succeed-2024-10-09/
Roche CEO: breast cancer pill could enter $12 bln market if trials succeed
Key FactsRoche CEO: Breast Cancer Pill Could Reach Billion-Dollar Market
Oct 9, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: reuters.com
  • Roche's experimental drug giredestrant may tap into a market exceeding 10 billion Swiss francs if it passes two critical trials.

  • CEO Thomas Schinecker expressed confidence in the company's oncology initiatives while also diversifying into other therapy areas.

  • Competitors include AstraZeneca and Sanofi, with the latter halting its similar oral SERD project after two trial failures in 2022.

  • Results from the two key giredestrant trials are expected next year and in 2026, focusing on newly diagnosed cases.
1 similar article
0
4 0
0
0 1
Profile picture of Bloomberg
Bloomberg
B+
 Apr 24 24
Roche Cuts Pipeline After Research Setbacks and Sales Drop: Roche Holding AG cut a fifth of its pipeline of experimental drugs in recent quarters as its new ...
bloomberg.com/news/articles/2024-04-24/roche-sales-decline-in-last-quarter-of-pandemic-impact
Roche Cuts Pipeline After Research Setbacks and Sales Drop
1 similar article
0
1
0
4
Profile picture of verlagshaus-jaumann.de
verlagshaus-jaumann.de
C
 Feb 02 24
Basel - Roche is under pressure: Copycat products and lost Covid-19 sales continue to cause problems for the Basel-based pharmaceutical company.
verlagshaus-jaumann.de/inhalt.basel-roche-steht-unter-druck.c90f8fb7-1273-4c7e-b6d0-d5b7710021ab.html
Basel - Roche is under pressure
4 similar articles
0
1
0
0
Profile picture of Reuters
Reuters
A
 Oct 24 23
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug: Swiss pharmaceutical company Roche (ROG.S) has settled a patent lawsuit against U ...
reuters.com/business/healthcare-pharmaceuticals/roche-settles-us-patent-lawsuit-against-biogen-over-blockbuster-arthritis-drug-2023-10-23/
Roche settles US patent lawsuit against Biogen over blockbuster arthritis ...
13 similar articles
0
3 2
Profile picture of Reuters
Reuters
A
 Oct 19 23
Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales: Quarterly sales at Switzerland's Roche (ROG.S) slipped 3% as a slump in COVID-19 product ...
reuters.com/business/healthcare-pharmaceuticals/roches-9m-sales-down-6-currency-headwinds-drop-covid-sales-2023-10-19/
Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales
Key FactsRoche Reports 3% Decline in Q3 Sales
Oct 19, 2023 · Reading time: ~30 sec.
Summary created with AI assistance · Source: reuters.com
  • Vabysmo eye drug exceeds expectations

  • Quarterly sales meet market expectations

  • CEO not in a rush for external deals and partnerships

  • Shares decline due to disappointing guidance
3 similar articles
0
12 2
0
1
Profile picture of The Sydney Morning Herald
The Sydney Morning Herald
B+
 Feb 17 23
The $1.3 billion share sale that has rocked one of the world’s richest families: It was the sort of thing that happened once a generation — at most ...
smh.com.au/business/the-economy/the-1-3-billion-share-sale-that-has-rocked-one-of-the-world-s-richest-families-20230215-p5ckky.html
The $1.3 billion share sale that has rocked one of the world’s richest ...
0 similar articles
0
1
0
4
Profile picture of finanzen.net
finanzen.net
C
 Feb 02 23
Roche share: Roche meets own expectations in 2022 - 2023 sales and profit decline expected
finanzen.net/nachricht/aktien/umsatz-stabil-gehalten-roche-aktie-roche-erreicht-2022-eigene-erwartungen-2023-umsatz-und-gewinnrueckgang-erwartet-12125853
Roche share: Roche meets own expectations in 2022 - 2023 sales and profit ...
0
1
Profile picture of Kleine Zeitung
Kleine Zeitung
C
 Oct 19 22
Study confirms Paxlovid ''considerable additional benefit'': Paxlovid is shown to be effective as a drug against Covid-19 in another study. However ...
kleinezeitung.at/lebensart/gesundheit/6201905/CovidMedikament_Untersuchung-bescheinigt-Paxlovid-erheblichen
Study confirms Paxlovid ''considerable additional benefit''
4 similar articles
0
23
Next